In this study, we integrated bulk RNA-seq and scRNA-seq data to identify an immune-related gene signature—THEMIS2, SIGLEC9, CSTA, LILRB3, and MS4A6A—that is strongly associated with poor survival in GBM. This evidence concerns the gene SIGLEC9 and glioblastoma.